Integrin-mediated cancer progression as a specific target in clinical therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrin-mediated cancer progression as a specific target in clinical therapy
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 155, Issue -, Pages 113745
Publisher
Elsevier BV
Online
2022-09-28
DOI
10.1016/j.biopha.2022.113745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
- (2021) Francesco Pantano et al. ONCOGENE
- Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells
- (2021) Jisu Jeong et al. Frontiers in Pharmacology
- CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
- (2021) Jianjie Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Antitumor Immunity
- (2021) Youhua Zhang et al. Cancer Immunology Research
- Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts
- (2021) Changsong Wang et al. BMC CANCER
- Inhibition of integrin subunit alpha 11 restrains gastric cancer progression through phosphatidylinositol 3-kinase/Akt pathway
- (2021) Haijun Zhang et al. Bioengineered
- TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells
- (2020) Sofia M.E. Weiler et al. CANCER LETTERS
- The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration
- (2020) Xiaoduan Li et al. CELLULAR ONCOLOGY
- Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway
- (2020) Caihong Wang et al. Cell Reports
- Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin
- (2020) Renata Machado Brandão-Costa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fibrinogen Alpha Chain Knockout Promotes Tumor Growth and Metastasis through Integrin-AKT Signaling Pathway in Lung Cancer
- (2020) Meng Wang et al. MOLECULAR CANCER RESEARCH
- Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway
- (2020) Ning Wang et al. Human Cell
- THBS4 promotes HCC progression by regulating ITGB1 via FAK/PI3K/AKT pathway
- (2020) Dan Guo et al. FASEB JOURNAL
- Roles of Membrane Domains in Integrin-Mediated Cell Adhesion
- (2020) Daniel Lietha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
- (2020) Suyanee Thongchot et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
- (2019) L. Zhang et al. Clinical & Translational Oncology
- Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting
- (2019) Jiansong Huang et al. Journal of Hematology & Oncology
- NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
- (2019) Hongfei Yan et al. Cancer Management and Research
- Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway
- (2019) Xiangbin Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway
- (2019) Xiao-xiao Zuo et al. Cell Communication and Signaling
- Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
- (2019) Fengkai Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins
- (2019) Bijiao Zhou et al. ONCOGENE
- Integrin β4–Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
- (2019) Shasha Ruan et al. CANCER RESEARCH
- Integrin α11 in non–small cell lung cancer is associated with tumor progression and postoperative recurrence
- (2019) Takahiro Ando et al. CANCER SCIENCE
- Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma
- (2019) Jun-Chen Ge et al. CELLULAR SIGNALLING
- Dietary delphinidin inhibits human colorectal cancer metastasis associating with upregulation of miR-204-3p and suppression of the integrin/FAK axis
- (2019) Chi-Chou Huang et al. Scientific Reports
- Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
- (2018) Jonas Schnittert et al. ADVANCED DRUG DELIVERY REVIEWS
- Blockade of ITGA2 Induces Apoptosis and Inhibits Cell Migration in Gastric Cancer
- (2018) Yu-Chang Chuang et al. BIOLOGICAL PROCEDURES ONLINE
- Integrin diversity brings specificity in mechanotransduction
- (2018) Shailaja Seetharaman et al. BIOLOGY OF THE CELL
- SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin–Rho GTPase–Hippo Pathways
- (2018) Yan-Li Zhang et al. CANCER RESEARCH
- ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma
- (2018) Yong Li et al. EXPERIMENTAL CELL RESEARCH
- The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells
- (2018) Y. K. Stella Man et al. MOLECULAR CANCER THERAPEUTICS
- Prostate cancer sheds the αvβ3 integrin in vivo through exosomes
- (2018) Shiv Ram Krishn et al. MATRIX BIOLOGY
- Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts
- (2018) Cheng Peng et al. BIOSCIENCE REPORTS
- Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway
- (2017) Xiaofeng Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
- (2017) Rehman Ata et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
- (2017) Xiangsheng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
- (2017) Byron H. Kwan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy
- (2017) Naoki Hosen et al. NATURE MEDICINE
- The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human α V β 3 Integrin via Steric Hindrance
- (2017) Andrew J. Borst et al. STRUCTURE
- Potential of Integrin Inhibitors for Treating Ovarian Cancer: A Literature Review
- (2017) et al. Cancers
- The complexity of integrins in cancer and new scopes for therapeutic targeting
- (2016) Hellyeh Hamidi et al. BRITISH JOURNAL OF CANCER
- A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α2 integrin inhibitor E7820 in patients with advanced solid tumors
- (2016) B. Milojkovic Kerklaan et al. INVESTIGATIONAL NEW DRUGS
- A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
- (2016) Geert A. Cirkel et al. INVESTIGATIONAL NEW DRUGS
- Exosome-mediated Transfer of v 3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype
- (2016) A. Singh et al. MOLECULAR CANCER RESEARCH
- The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines
- (2016) Weiwei Cheng et al. OncoTargets and Therapy
- Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
- (2016) Xiao-Yan Ming et al. Nature Communications
- Integrin α6 promotes esophageal cancer metastasis and is targeted by miR-92b
- (2016) Gang Ma et al. Oncotarget
- Research advances on structure and biological functions of integrins
- (2016) Li Pan et al. SpringerPlus
- Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
- (2015) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- The αvβ6Integrin Is Transferred Intercellularly via Exosomes
- (2015) Carmine Fedele et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Colorectal Cancer Metastases Settle in the Hepatic Microenvironment Through α5β1 Integrin
- (2015) Chiara Pelillo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer
- (2015) R Navab et al. ONCOGENE
- Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression
- (2015) Guang-Yun Yang WORLD JOURNAL OF GASTROENTEROLOGY
- Silencing profilin-1 inhibits gastric cancer progressionviaintegrin β1/focal adhesion kinase pathway modulation
- (2015) Ya-Jun Cheng WORLD JOURNAL OF GASTROENTEROLOGY
- S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer
- (2015) Ya-Ling Hsu et al. Oncotarget
- Integrin activation
- (2015) Mark H. Ginsberg BMB Reports
- Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
- (2015) Charles N. Landen et al. NEOPLASIA
- Targeting of αv-Integrins in Stem/Progenitor Cells and Supportive Microenvironment Impairs Bone Metastasis in Human Prostate Cancer
- (2015) Geertje van der Horst et al. NEOPLASIA
- Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
- (2014) J. B. Vermorken et al. ANNALS OF ONCOLOGY
- Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models
- (2014) Ken Ito et al. CANCER SCIENCE
- Cilengitide, a small molecule antagonist, targeted to integrin αν inhibits proliferation and induces apoptosis of laryngeal cancer cells in vitro
- (2014) Jing Ting Wang et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Metastatic signature in lung cancer is associated with sensitivity to anti-integrin αVmonoclonal antibody intetumumab
- (2014) Huiqing Liu et al. GENES CHROMOSOMES & CANCER
- Atomic Basis for the Species-specific Inhibition of αV Integrins by Monoclonal Antibody 17E6 Is Revealed by the Crystal Structure of αVβ3 Ectodomain-17E6 Fab Complex
- (2014) Bhuvaneshwari Mahalingam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Integrin αvβ3 is required for cathepsin B-induced hepatocellular carcinoma progression
- (2014) ZONG-ZHEN XU et al. Molecular Medicine Reports
- β1 integrin modulates tumor growth and apoptosis of human colorectal cancer
- (2014) JIA SONG et al. ONCOLOGY REPORTS
- 1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGF -miR-200-ZEB Network in E-Cadherin-Positive Triple-Negative Breast Cancer
- (2014) H. H. Truong et al. Science Signaling
- β1 integrin mediates colorectal cancer cell proliferation and migration through regulation of the Hedgehog pathway
- (2014) Jia Song et al. TUMOR BIOLOGY
- Investigational Analysis Reveals a Potential Role for Neutrophils in Giant-Cell Arteritis Disease Progression
- (2013) Suchita Nadkarni et al. CIRCULATION RESEARCH
- Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma
- (2013) JUNHYE KWON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Differentiation of Pancreatic Tumor-Initiating Cells by Vitronectin Can Be Blocked by Cilengitide
- (2013) Stephanie M. Cabarcas et al. PANCREAS
- Integrins and metastasis
- (2013) Kirat Kumar Ganguly et al. Cell Adhesion & Migration
- A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human αν integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer
- (2012) A. Heidenreich et al. ANNALS OF ONCOLOGY
- Dual inhibition of αV integrins and Src kinase activity as a combination therapy strategy for colorectal cancer
- (2012) Jingquan Jia et al. ANTI-CANCER DRUGS
- A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306)
- (2012) L. Burt Nabors et al. CANCER
- Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways
- (2012) A Bianchi-Smiraglia et al. ONCOGENE
- Knockdown of integrin α3β1 expression induces proliferation and migration of non-small cell lung cancer cells
- (2012) HYUN JAE YOON et al. ONCOLOGY REPORTS
- Integrin Targeted Therapeutics
- (2012) Melissa Millard et al. Theranostics
- Targeting tumor cell motility to prevent metastasis
- (2011) Trenis D. Palmer et al. ADVANCED DRUG DELIVERY REVIEWS
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- Phase I Study of E7820, an Oral Inhibitor of Integrin -2 Expression with Antiangiogenic Properties, in Patients with Advanced Malignancies
- (2011) M. Mita et al. CLINICAL CANCER RESEARCH
- 1-Integrin: A Potential Therapeutic Target in the Battle against Cancer Recurrence
- (2011) D. Barkan et al. CLINICAL CANCER RESEARCH
- Volociximab in cancer
- (2011) Salah Almokadem et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Integrin α3β1 as a breast cancer target
- (2011) Sita Subbaram et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting integrins in hepatocellular carcinoma
- (2011) Yanhua Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody
- (2011) Marta Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Integrin 5 1 facilitates cancer cell invasion through enhanced contractile forces
- (2011) C. T. Mierke et al. JOURNAL OF CELL SCIENCE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Integrin Structure, Activation, and Interactions
- (2011) I. D. Campbell et al. Cold Spring Harbor Perspectives in Biology
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
- (2010) Ajjai Alva et al. INVESTIGATIONAL NEW DRUGS
- The α2β1 integrin is a metastasis suppressor in mouse models and human cancer
- (2010) Norma E. Ramirez et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrin α6Bβ4 inhibits colon cancer cell proliferation and c-Myc activity
- (2009) Anders Bondo Dydensborg et al. BMC CANCER
- Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients
- (2009) Chee M. Ng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Integrins
- (2008) Rita Silva et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- CYR61 and V 5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma
- (2008) Y. Monnier et al. CANCER RESEARCH
- Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds 5 1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
- (2008) A. D. Ricart et al. CLINICAL CANCER RESEARCH
- Transforming growth factor-β1 increases cell migration and β1 integrin up-regulation in human lung cancer cells
- (2008) Yi-Chin Fong et al. LUNG CANCER
- Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo
- (2008) Shoucheng Ning et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started